In order to improve siRNA stability and reduce “on-target, off-tumor” toxicity, the tumor cell membrane was utilized to coat PLGA nanoparticles containing programmed cell death 1 ligand 1 (PD-L1) siRNA. The gene discussed is CD274; the disease is neoplasm.